Please provide your email address to receive an email when new articles are posted on . Good vascular access continues to be a cornerstone of optimal hemodialysis (HD) for patients with end-stage ...

Background: A significant decrease in catheter-related infections was demonstrated in our earlier randomized controlled trial of central venous catheter (CVC) care in hematologic patients. Objective: ...

In response to a high infection rate in a critical care unit, a project improved infection-control practices. This initiative won the Infection Prevention and Control category in the 2022 Nursing ...

Objective: Following the introduction and widespread use of central venous catheters (CVCs) in adults, these devices are being used with increasing frequency in the pediatric population. This review ...

Please provide your email address to receive an email when new articles are posted on . Study findings indicated that although most patients who had insurance before developing end-stage renal disease ...

WAYNE, Pa., June 12, 2025 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced findings from a new multinational study reporting ...

The Food and Drug Administration (FDA) has approved DefenCath ® (taurolidine and heparin) catheter lock solution to reduce the incidence of catheter-related bloodstream infections (CRBSI) in adult ...

In this prospective study, we assessed the incidence of central venous catheter (CVC)-related thrombosis in haematopoietic stem cell transplant (HSCT) recipients. We determined the contribution of ...

Catheter-related bloodstream infections are associated with recognized morbidity and mortality. Accurate diagnosis of such infections results in proper management of patients and in reducing ...

During a 25-month period, 203 pediatric patients who had newly placed Broviac-Hickman CVCs were randomly assigned to standard flushing with heparin solution or to experimental flushing with normal ...